• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人源拓扑异构酶 IIα 的 ATP 酶结构域中 ATP 水解的催化机制。

Catalytic Mechanism of ATP Hydrolysis in the ATPase Domain of Human DNA Topoisomerase IIα.

机构信息

National Institute of Chemistry, Hajdrihova 19, SI-1001 Ljubljana, Slovenia.

Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, SI 1000 Ljubljana, Slovenia.

出版信息

J Chem Inf Model. 2022 Aug 22;62(16):3896-3909. doi: 10.1021/acs.jcim.2c00303. Epub 2022 Aug 10.

DOI:10.1021/acs.jcim.2c00303
PMID:35948041
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9400105/
Abstract

Human DNA topoisomerase IIα is a biological nanomachine that regulates the topological changes of the DNA molecule and is considered a prime target for anticancer drugs. Despite intensive research, many atomic details about its mechanism of action remain unknown. We investigated the ATPase domain, a segment of the human DNA topoisomerase IIα, using all-atom molecular simulations, multiscale quantum mechanics/molecular mechanics (QM/MM) calculations, and a point mutation study. The results suggested that the binding of ATP affects the overall dynamics of the ATPase dimer. Reaction modeling revealed that ATP hydrolysis favors the dissociative substrate-assisted reaction mechanism with the catalytic Glu87 serving to properly position and polarize the lytic water molecule. The point mutation study complemented our computational results, demonstrating that Lys378, part of the important QTK loop, acts as a stabilizing residue. The work aims to pave the way to a deeper understanding of these important molecular motors and to advance the development of new therapeutics.

摘要

人类 DNA 拓扑异构酶 IIα 是一种调控 DNA 分子拓扑变化的生物纳米机器,被认为是抗癌药物的主要靶点。尽管进行了深入的研究,但该分子的作用机制仍有许多原子细节尚不清楚。我们使用全原子分子模拟、多尺度量子力学/分子力学(QM/MM)计算和点突变研究,对人类 DNA 拓扑异构酶 IIα 的 ATP 酶结构域进行了研究。结果表明,ATP 的结合会影响 ATP 酶二聚体的整体动力学。反应建模揭示了 ATP 水解有利于具有催化 Glu87 适当定位和极化裂解水分子的解联底物辅助反应机制。点突变研究补充了我们的计算结果,表明 QTK 环的一部分重要残基 Lys378 作为稳定残基发挥作用。这项工作旨在为深入了解这些重要的分子马达铺平道路,并推进新疗法的开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb5/9400105/0eca940c6a93/ci2c00303_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb5/9400105/f8218b5e6d32/ci2c00303_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb5/9400105/4ea5089af0eb/ci2c00303_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb5/9400105/464924348646/ci2c00303_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb5/9400105/29c39ee4616c/ci2c00303_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb5/9400105/c2d1bc60e8e3/ci2c00303_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb5/9400105/0eca940c6a93/ci2c00303_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb5/9400105/f8218b5e6d32/ci2c00303_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb5/9400105/4ea5089af0eb/ci2c00303_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb5/9400105/464924348646/ci2c00303_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb5/9400105/29c39ee4616c/ci2c00303_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb5/9400105/c2d1bc60e8e3/ci2c00303_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb5/9400105/0eca940c6a93/ci2c00303_0007.jpg

相似文献

1
Catalytic Mechanism of ATP Hydrolysis in the ATPase Domain of Human DNA Topoisomerase IIα.人源拓扑异构酶 IIα 的 ATP 酶结构域中 ATP 水解的催化机制。
J Chem Inf Model. 2022 Aug 22;62(16):3896-3909. doi: 10.1021/acs.jcim.2c00303. Epub 2022 Aug 10.
2
The QTK loop is essential for the communication between the N-terminal atpase domain and the central cleavage--ligation region in human topoisomerase IIalpha.QTK环对于人类拓扑异构酶IIα中N端ATP酶结构域与中心切割-连接区域之间的通讯至关重要。
Biochemistry. 2009 Jul 14;48(27):6508-15. doi: 10.1021/bi9005978.
3
Gambogic acid inhibits the catalytic activity of human topoisomerase IIalpha by binding to its ATPase domain.藤黄酸通过结合人拓扑异构酶IIα的ATP酶结构域来抑制其催化活性。
Mol Cancer Ther. 2007 Sep;6(9):2429-40. doi: 10.1158/1535-7163.MCT-07-0147.
4
The p53 tumor suppressor stimulates the catalytic activity of human topoisomerase IIalpha by enhancing the rate of ATP hydrolysis.p53肿瘤抑制蛋白通过提高ATP水解速率来刺激人拓扑异构酶IIα的催化活性。
J Biol Chem. 2000 Jun 16;275(24):18503-10. doi: 10.1074/jbc.M002081200.
5
Novel xanthone-polyamine conjugates as catalytic inhibitors of human topoisomerase IIα.新型氧杂蒽酮-多胺共轭物作为人拓扑异构酶IIα的催化抑制剂
Bioorg Med Chem Lett. 2017 Oct 15;27(20):4687-4693. doi: 10.1016/j.bmcl.2017.09.011. Epub 2017 Sep 8.
6
Communication between the ATPase and cleavage/religation domains of human topoisomerase IIalpha.人拓扑异构酶IIα的ATP酶结构域与切割/连接结构域之间的通讯
J Biol Chem. 2000 Apr 28;275(17):13041-8. doi: 10.1074/jbc.275.17.13041.
7
4,6-Substituted-1,3,5-triazin-2(1H)-ones as monocyclic catalytic inhibitors of human DNA topoisomerase IIα targeting the ATP binding site.4,6-取代-1,3,5-三嗪-2(1H)-酮作为靶向ATP结合位点的人DNA拓扑异构酶IIα的单环催化抑制剂。
Bioorg Med Chem. 2015 Aug 1;23(15):4218-4229. doi: 10.1016/j.bmc.2015.06.049. Epub 2015 Jul 2.
8
The DNA dependence of the ATPase activity of human DNA topoisomerase IIalpha.人DNA拓扑异构酶IIα的ATP酶活性对DNA的依赖性
J Biol Chem. 1997 Dec 19;272(51):32696-703. doi: 10.1074/jbc.272.51.32696.
9
Nucleotide-dependent domain movement in the ATPase domain of a human type IIA DNA topoisomerase.人IIA型DNA拓扑异构酶ATP酶结构域中核苷酸依赖性结构域运动
J Biol Chem. 2005 Nov 4;280(44):37041-7. doi: 10.1074/jbc.M506520200. Epub 2005 Aug 12.
10
The N-terminal domain of human topoisomerase IIalpha is a DNA-dependent ATPase.人类拓扑异构酶IIα的N端结构域是一种依赖DNA的ATP酶。
Biochemistry. 1998 Dec 1;37(48):16997-7004. doi: 10.1021/bi9818321.

引用本文的文献

1
Structural insights into fungal and human topoisomerase II with implications for in silico antifungal drug design.对真菌和人类拓扑异构酶II的结构见解及其对计算机辅助抗真菌药物设计的启示。
Sci Rep. 2025 Mar 19;15(1):9467. doi: 10.1038/s41598-025-93122-1.
2
Simulation- and AI-directed optimization of 4,6-substituted 1,3,5-triazin-2(1)-ones as inhibitors of human DNA topoisomerase IIα.作为人类DNA拓扑异构酶IIα抑制剂的4,6-取代-1,3,5-三嗪-2(1)-酮的模拟与人工智能导向优化
Comput Struct Biotechnol J. 2024 Jul 6;23:2995-3018. doi: 10.1016/j.csbj.2024.06.037. eCollection 2024 Dec.
3
Modeling allosteric mechanisms of eukaryotic type II topoisomerases.

本文引用的文献

1
Structural Dynamics and Catalytic Mechanism of ATP13A2 (PARK9) from Simulations.基于模拟的 ATP13A2(PARK9)的结构动力学和催化机制。
J Phys Chem B. 2021 Nov 4;125(43):11835-11847. doi: 10.1021/acs.jpcb.1c05337. Epub 2021 Oct 22.
2
Structural basis for allosteric regulation of Human Topoisomerase IIα.别构调节人拓扑异构酶 IIα 的结构基础。
Nat Commun. 2021 May 20;12(1):2962. doi: 10.1038/s41467-021-23136-6.
3
Substituted 4,5'-Bithiazoles as Catalytic Inhibitors of Human DNA Topoisomerase IIα.作为人类DNA拓扑异构酶IIα催化抑制剂的取代4,5'-联噻唑
建模真核 II 型拓扑异构酶的变构机制。
Biophys J. 2024 Jun 18;123(12):1620-1634. doi: 10.1016/j.bpj.2024.05.004. Epub 2024 May 8.
4
Structure-function analysis of the ATPase domain of African swine fever virus topoisomerase.非洲猪瘟病毒拓扑异构酶 ATP 酶结构域的结构功能分析。
mBio. 2024 Apr 10;15(4):e0308623. doi: 10.1128/mbio.03086-23. Epub 2024 Feb 27.
5
Unveiling the interdomain dynamics of type II DNA topoisomerase through all-atom simulations: Implications for understanding its catalytic cycle.通过全原子模拟揭示II型DNA拓扑异构酶的结构域间动力学:对理解其催化循环的启示
Comput Struct Biotechnol J. 2023 Jul 22;21:3746-3759. doi: 10.1016/j.csbj.2023.07.019. eCollection 2023.
6
Extensive Bioinformatics Analyses Reveal a Phylogenetically Conserved Winged Helix (WH) Domain (Zτ) of Topoisomerase IIα, Elucidating Its Very High Affinity for Left-Handed Z-DNA and Suggesting Novel Putative Functions.广泛的生物信息学分析揭示拓扑异构酶 IIα 具有系统进化保守的翼状螺旋(WH)结构域(Zτ),阐明其对左手 Z-DNA 的极高亲和力,并提出新的潜在功能。
Int J Mol Sci. 2023 Jun 27;24(13):10740. doi: 10.3390/ijms241310740.
7
Phenotypic Discovery of Thiocarbohydrazone with Anticancer Properties and Catalytic Inhibition of Human DNA Topoisomerase IIα.具有抗癌特性的硫代碳酰肼的表型发现及其对人DNA拓扑异构酶IIα的催化抑制作用
Pharmaceuticals (Basel). 2023 Feb 23;16(3):341. doi: 10.3390/ph16030341.
J Chem Inf Model. 2020 Jul 27;60(7):3662-3678. doi: 10.1021/acs.jcim.0c00202. Epub 2020 Jun 22.
4
Design and synthesis of 3,5-substituted 1,2,4-oxadiazoles as catalytic inhibitors of human DNA topoisomerase IIα.设计和合成 3,5-取代的 1,2,4-噁二唑类化合物作为人源拓扑异构酶 IIα 的催化抑制剂。
Bioorg Chem. 2020 Jun;99:103828. doi: 10.1016/j.bioorg.2020.103828. Epub 2020 Apr 8.
5
Mechanistic insights into the phosphoryl transfer reaction in cyclin-dependent kinase 2: A QM/MM study.细胞周期蛋白依赖性激酶 2 中磷酸转移反应的机制研究:QM/MM 研究。
PLoS One. 2019 Sep 4;14(9):e0215793. doi: 10.1371/journal.pone.0215793. eCollection 2019.
6
Structure-guided optimization of 4,6-substituted-1,3,5-triazin-2(1H)-ones as catalytic inhibitors of human DNA topoisomerase IIα.基于结构的人源拓扑异构酶 IIα 催化抑制剂 4,6-取代-1,3,5-三嗪-2(1H)-酮类化合物的优化。
Eur J Med Chem. 2019 Aug 1;175:330-348. doi: 10.1016/j.ejmech.2019.04.055. Epub 2019 Apr 25.
7
Studying the phosphoryl transfer mechanism of the phosphofructokinase-2: from X-ray structure to quantum mechanics/molecular mechanics simulations.研究磷酸果糖激酶-2的磷酰基转移机制:从X射线结构到量子力学/分子力学模拟
Chem Sci. 2019 Jan 28;10(10):2882-2892. doi: 10.1039/c9sc00094a. eCollection 2019 Mar 14.
8
Molecular Mechanism of ATP Hydrolysis in an ABC Transporter.ABC转运蛋白中ATP水解的分子机制。
ACS Cent Sci. 2018 Oct 24;4(10):1334-1343. doi: 10.1021/acscentsci.8b00369. Epub 2018 Oct 5.
9
Avoiding False Positive Conclusions in Molecular Simulation: The Importance of Replicas.避免分子模拟中的假阳性结论:复制品的重要性。
J Chem Theory Comput. 2018 Dec 11;14(12):6127-6138. doi: 10.1021/acs.jctc.8b00391. Epub 2018 Nov 9.
10
Structural insights into the gating of DNA passage by the topoisomerase II DNA-gate.拓扑异构酶 II DNA 门控结构对 DNA 通道的调控机制研究进展
Nat Commun. 2018 Aug 6;9(1):3085. doi: 10.1038/s41467-018-05406-y.